Clinical Pharmacology of Eptifibatide
- 1 August 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (4) , 11B-20B
- https://doi.org/10.1016/s0002-9149(97)00572-9
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Antiplatelet therapyThe American Journal of Medicine, 1996
- Recognition and Treatment of Unstable AnginaDrugs, 1996
- Antiplatelet and anticoagulant use after myocardial infarctionClinical Cardiology, 1996
- NOVEL ANTITHROMBOTIC THERAPEUTICS TARGETED AGAINST PLATELET GLYCOPROTEIN IIb/IIIaAnnual Review of Medicine, 1995
- Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.Circulation, 1994
- Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1994
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- The platelet membrane glycoprotein IIb-IIIa complexBlood, 1988
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976